Summary |
|
||||||||||||
Mutation origin |
|
||||||||||||
Mutation description |
|
||||||||||||
Phenotypes |
![]()
View phenotypes and curated references for all genotypes (concatenated display).
|
||||||||||||
Expression |
|
||||||||||||
Tumor Data |
|
||||||||||||
Find Mice (IMSR) |
|
||||||||||||
Notes |
Loss of Ptgir was shown functionally: e.g., a prostacyclin analogue (cicaprost) was used to inhibit platelet aggregation induced by ADP (platelet aggregation was inhibited in wild-type mice, but not in homozygous mutant mice), relaxation of smooth muscle in aortic rings of wild-type and homozygous mutant mice was measured after stimulation with a prostacyclin analogue (cicaprost, again, homozygous mutant mice showed no relaxation upon stimulation). Specificity of the knock-out was demonstrated by functional assay using other prostaglandins (e.g., PGE2). No differences between wild-type and homozygous mutant deficient mice were seen in response to PGE2. |
||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|